Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : email@example.com
|Drug Name||Anti-CD19 CAR T cells|
Anti-CD19 CAR T cells are T-cells that express a chimeric antigen receptor that targets the CD19 surface protein on B-lymphocytes, which results in anti-tumor activity in B-cell malignancies (PMID: 25999455, PMID: 26425336).
|CAS Registry Number||NA|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|ABT-737 + Anti-CD19 CAR T cells||ABT-737 Anti-CD19 CAR T cells||0||0|
|Anti-CD19 CAR T cells||Anti-CD19 CAR T cells||1||4|
|Anti-CD19 CAR T cells + Cyclophosphamide + Fludarabine||Anti-CD19 CAR T cells Cyclophosphamide Fludarabine||0||1|
|Anti-CD19 CAR T cells + Cyclophosphamide + Fludarabine + Rituximab||Anti-CD19 CAR T cells Cyclophosphamide Fludarabine Rituximab||0||1|